Table of Contents:
  • 1. From Traditional Medicine to Modern Drugs: Historical Perspective of Structure-Based Drug Design
  • Part One Concepts, Tools, Ligands, and Scaffolds for Structure-Based Design of Inhibitors
  • 2. Design of Inhibitors of Aspartic Acid Proteases
  • 3. Design of Serine Protease Inhibitors
  • 4. Design of Proteasome Inhibitors
  • 5. Design of Cysteine Protease Inhibitors
  • 6. Design of Metalloprotease Inhibitors
  • 7. Structure-Based Design of Protein Kinase Inhibitors
  • 8. Protein X-Ray Crystallography in Structure-Based Drug Design
  • 9. Structure-Based Design Strategies for Targeting G-Protein-Coupled Receptors (GPCRs)
  • Part Two Structure-Based Design of FDA-Approved Inhibitor Drugs and Drugs Undergoing Clinical Development
  • 10. Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertension: Design and Discovery of Captopril.
  • 11. HIV-1 Protease Inhibitors for the Treatment of HIV Infection and AIDS: Design of Saquinavir, Indinavir, and Darunavir
  • 12. Protein Kinase Inhibitor Drugs for Targeted Cancer Therapy: Design and Discovery of Imatinib, Nilotinib, Bafetinib, and Dasatinib
  • 13. NS3/4A Serine Protease Inhibitors for the Treatment of HCV: Design and Discovery of Boceprevir and Telaprevir
  • 14. Proteasome Inhibitors for the Treatment of Relapsed Multiple Myeloma: Design and Discovery of Bortezomib and Carfilzomib
  • 15. Development of Direct Thrombin Inhibitor, Dabigatran Etexilate, as an Anticoagulant Drug
  • 16. Non-Nucleoside HIV Reverse Transcriptase Inhibitors for the Treatment of HIV/AIDS: Design and Development of Etravirine and Rilpivirine
  • 17. Renin Inhibitor for the Treatment of Hypertension: Design and Discovery of Aliskiren
  • 18. Neuraminidase Inhibitors for the Treatment of Influenza: Design and Discovery of Zanamivir and Oseltamivir
  • 19. Carbonic Anhydrase Inhibitors for the Treatment of Glaucoma: Design and Discovery of Dorzolamide
  • 20 B-Secretase Inhibitors for the Treatment of Alzheimer's Disease: Preclinical and Clinical Inhibitors.